Published in Pediatr Blood Cancer on June 23, 2011
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood (2012) 1.86
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol (2008) 1.63
A parent's point of view on the American Academy of Pediatrics policy statement: Children as hematopoietic stem cell donors. Pediatr Blood Cancer (2011) 1.52
Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant (2007) 1.44
Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin Infect Dis (2010) 1.33
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33
Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biol Blood Marrow Transplant (2005) 1.17
Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant (2010) 1.15
Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee. Pediatr Blood Cancer (2006) 1.13
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults. Antimicrob Agents Chemother (2011) 1.10
Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. Mol Genet Metab (2005) 1.07
Hospice referral practices for children with cancer: a survey of pediatric oncologists. J Clin Oncol (2006) 1.04
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant (2010) 1.01
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults. Antimicrob Agents Chemother (2011) 0.98
Schimke Immunoosseous Dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child. Pediatr Blood Cancer (2013) 0.96
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant (2005) 0.94
Initial vancomycin dosing in pediatric oncology and stem cell transplant patients. J Pediatr Hematol Oncol (2009) 0.93
Acute lymphoblastic leukemia. J Natl Compr Canc Netw (2012) 0.93
Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer (2004) 0.92
Influenza immunization practices among pediatric oncologists. J Pediatr Hematol Oncol (2003) 0.92
Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant (2009) 0.90
Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. Pediatr Blood Cancer (2013) 0.87
t(17;19) in Children with Acute Lymphocytic Leukemia: A Report of 3 Cases and a Review of the Literature. Case Rep Hematol (2013) 0.87
A cord blood transplant recipient with Mycobacterium mucogenicum central venous catheter infection after infusion of tap water. Pediatr Infect Dis J (2006) 0.86
Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature. J Pediatr Hematol Oncol (2005) 0.85
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant (2010) 0.83
New allergies after cord blood transplantation. Cytotherapy (2013) 0.82
Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan. Pediatr Transplant (2013) 0.82
Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: functional characterization and a review of the literature. Exp Hematol (2009) 0.82
Long-term follow-up and management guidelines in pediatric patients after allogenic hematopoietic stem cell transplantation. Semin Hematol (2012) 0.81
Incidence, risk factors, and outcome of pneumatosis intestinalis in pediatric stem cell transplant recipients. Pediatr Blood Cancer (2011) 0.81
Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature. J Pediatr Hematol Oncol (2004) 0.81
A case of pediatric PTLD following autologous stem cell transplantation and review of the literature. Pediatr Transplant (2010) 0.80
Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy. Am J Cardiol (2012) 0.80
Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia. Pediatr Transplant (2013) 0.80
Risk of subsequent malignancies in survivors of childhood leukemia. J Cancer Surviv (2013) 0.80
Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Pediatr Transplant (2007) 0.79
Bone marrow transplantation in phosphoglycerate kinase (PGK) deficiency. Br J Haematol (2011) 0.78
Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium. Biol Blood Marrow Transplant (2010) 0.78
Allogeneic hematopoietic stem cell transplantation for infants with idiopathic myelofibrosis. Pediatr Transplant (2013) 0.78
Human rhinovirus C infections in pediatric hematology and oncology patients. Pediatr Transplant (2014) 0.77
Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer (2013) 0.77
Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient. Pediatr Transplant (2014) 0.77
Effects of Race/Ethnicity and Socioeconomic Status on Outcome in Childhood Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol (2016) 0.76
Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy (2010) 0.76
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy. Pediatr Blood Cancer (2007) 0.76
Comparison of pre-cryopreserved and post-thaw-and-wash-nucleated cell count on major outcomes following unrelated cord blood transplant in children. Pediatr Transplant (2012) 0.76
Unrelated stem cell transplant for infantile idiopathic myelofibrosis. Pediatr Blood Cancer (2009) 0.76
Severe ehrlichia infection in pediatric oncology and stem cell transplant patients. Pediatr Blood Cancer (2010) 0.75
Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood (2009) 0.75
Is it time to consider early discharge for pediatric patients after hematopoietic stem cell transplant? Pediatr Transplant (2014) 0.75
Safety and feasibility of granulocyte colony-stimulating factor (G-CSF) primed bone marrow (BM) using three days of G-CSF priming as stem cell source for pediatric allogeneic BM transplantation. Pediatr Transplant (2014) 0.75
Mobilization of Ph chromosome-negative peripheral blood stem cells in a child with chronic myeloid leukemia after imatinib-induced complete molecular remission. Pediatr Blood Cancer (2008) 0.75
Incidence and risk factors for cytomegalovirus (CMV) reactivation following autologous hematopoietic stem cell transplantation in children. Pediatr Blood Cancer (2014) 0.75
Direct provider feedback to decrease chemotherapy ordering errors: the "gray envelope" initiative. Pediatr Blood Cancer (2012) 0.75
Shortage of chemotherapeutic agents in Iraq and outcome of childhood acute lymphocytic leukemia, 1990-2002. N Engl J Med (2008) 0.75
Disparity in Outcomes for Adolescent and Young Adult Patients Diagnosed With Pediatric Solid Tumors Across 4 Decades. Am J Clin Oncol (2016) 0.75
Significant inconsistency among pediatric oncologists in the use of the neutropenic diet. Pediatr Blood Cancer (2014) 0.75
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma. Pediatr Blood Cancer (2009) 0.75
Unrelated bone marrow transplant for congenital amegakaryocytic thrombocytopenia: report of two cases and review of the literature. Pediatr Transplant (2009) 0.75
A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature. J Pediatr Hematol Oncol (2011) 0.75
Castleman disease in a pediatric liver transplant recipient: a case report and literature review. Pediatr Transplant (2011) 0.75
Effect of acute graft-versus-host disease on the outcome of second allogeneic hematopoietic stem cell transplant in children. Leuk Lymphoma (2012) 0.75